Identification of human lymphocyte subpopulations by surface marker analysis.

Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med (1980) 6.49

Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest (1985) 2.28

Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies. Immunology (1982) 0.94

Polyamine-polyamine oxidase interaction: part of maternal protective mechanism against fetal rejection. Br Med J (1980) 0.94

Maturation-linked expression of C3b and C3b' receptors on developing human bone marrow and peripheral blood granulocytes. Clin Exp Immunol (1981) 0.91

Immunologic diagnosis and monitoring of human acute leukemias: a review. Am J Pathol (1981) 0.90

Need for immunologic stimulators during immunosuppression produced by major cancer surgery. Ann Surg (1985) 0.87

Ultrastructural localization of acid phosphatase in rosetted T and B lymphocytes of normal human blood. Am J Pathol (1981) 0.83

Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1. Ann Rheum Dis (1991) 0.77

Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest (1973) 5.31

Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med (1973) 4.46

Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol (1985) 3.97

Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A (1977) 2.80

Membrane complement receptors specific for bound fragments of C3. Adv Immunol (1985) 2.80

Specificity of human lymphocyte complement receptors. J Exp Med (1975) 2.77

Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies. J Immunol (1981) 2.74

Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. J Immunol (1982) 2.68

Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest (1996) 2.68

Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol (1996) 2.41

Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes. J Exp Med (1982) 2.36

Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur J Immunol (1984) 2.20

Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system. J Immunol Methods (1980) 2.17

p150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur J Immunol (1985) 2.14

Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol (1985) 2.07

Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin. J Exp Med (1983) 2.07

Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin. J Exp Med (1980) 1.96

Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest (1988) 1.92

Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody. Proc Natl Acad Sci U S A (1981) 1.86

Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol (1985) 1.76

Membrane receptors of mouse leukocytes. II. Sequential expression of membrane receptors and phagocytic capacity during leukocyte differentiation. J Exp Med (1978) 1.69

The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol (1999) 1.61

The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils. J Exp Med (1978) 1.56

Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregation. J Immunol (1988) 1.56

Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1. Blood (1985) 1.44

Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement (1987) 1.35

Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med (1979) 1.31

Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol (1994) 1.30

Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol (1993) 1.26

Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype. J Exp Med (1982) 1.21

Assay for the two different types of lymphocyte complement receptors. Scand J Immunol (1976) 1.18

Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia (2004) 1.17

Structure and function of membrane complement receptors. Summary. Fed Proc (1982) 1.15

Surface markers of human eosinophils. Blood (1976) 1.13

Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. Immunopharmacology (2000) 1.12

Comparison of various tests for Fc receptors on different human lymphocyte sub populations. Clin Exp Immunol (1979) 1.10

Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol (1999) 1.09

Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d. J Immunol (1983) 1.09

gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). Eur J Immunol (1985) 1.05

Role of complement receptor type three and serum opsonins in the neutrophil response to yeast. Complement (1987) 1.05

Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18). J Immunol (1991) 1.04

Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G. J Clin Invest (1978) 1.03

Surface markers of complement receptor lymphocytes. J Clin Invest (1978) 1.03

Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18). J Immunol (1999) 1.01

Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres. J Immunol (1982) 0.99

Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol (1996) 0.95

CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J Clin Immunol (1993) 0.93

Surface markers of B and T cells. Recent technical developments reveal a heterogeneity of lymphocyte subpopulations. Arch Pathol Lab Med (1977) 0.92

Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules. Clin Exp Immunol (1999) 0.92

Phagocytosis by human monocyte-derived macrophages. Independent function of receptors for C3b (CR1) and iC3b (CR3). Complement (1984) 0.91

Clinical and laboratory features of patients with an inherited deficiency of neutrophil membrane complement receptor type 3 (CR3) and the related membrane antigens LFA-1 and p150,95. J Clin Immunol (1986) 0.90

Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. J Immunol (1993) 0.89

Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site. Complement (1987) 0.88

Membrane receptors of mouse leukocytes. I. Two types of complement receptors for different regions of C3. J Immunol (1978) 0.87

Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). J Immunol (1997) 0.87

Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosis. Eur J Cell Biol (1991) 0.85

A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18). Clin Exp Immunol (1998) 0.83

Isolation and purification of C3 from human plasma. Curr Protoc Immunol (2001) 0.79

Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b. Blood (1988) 0.76

Synthesis of complement component C5 by human B and T lymphoblastoid cell lines. Immunogenetics (1990) 0.75

Herbicide-treated hay as a possible cause of dermatitis in horses. Vet Rec (2009) 0.75

The complement receptor type 2 and factor H receptors. Methods Enzymol (1987) 0.75

Assays for membrane complement receptors. Curr Protoc Immunol (2001) 0.75

The first component (C1n) of the complement system of the nurse shark (Ginglymostoma cirratum). I. Hemolytic characteristics of partially purified C1n. J Immunol (1973) 0.75

Receptor deficiencies. Complement receptor type three. Prog Allergy (1986) 0.75

Characteristics of complement receptor-bearing cells in the spleens of tumor-bearing mice. J Immunol (1978) 0.75